Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1999
10/26/1999US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972720 Colloidal particles surface are co-adsorbed with biomolecules and polyoxyethylene qlycol substituted by thiol and/or disulfide groups; as detection reagent in an immunoassay
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade.
10/26/1999US5972666 Assembly-deficient herpesvirus vaccine
10/26/1999US5972659 Introducing into e. coli a heterologous plasmid expression vector coding for the tobacco mosaic virus protein coat and a pathogen's epitope, separating fusion protein and lowering ph to form a self-aggregated protein and hapten for vaccines
10/26/1999US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999US5972650 Can be used as vehicles for the delivery of nucleic acids that can serve as therapeutic agents and as part of vaccines designed to immunize people or animals against viral diseases.
10/26/1999US5972649 Polynucleotide sequence encoding human multiple endocrine neoplasia type 1 protein
10/26/1999US5972645 Flea serine protease nucleic acid molecules
10/26/1999US5972633 Antibodies against heart muscle actin
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999US5972597 Methods using modified vaccinia virus
10/26/1999US5972596 Nucleic acid constructs containing HIV genes with mutated inhibitory/instability regions and methods of using same
10/26/1999US5972353 Immunogenic amount of an immunologically active mn protein or m polypeptide effective to immunize a vertebrate against a neoplastic disease associated with expression of mn antigen
10/26/1999US5972352 Cloning of mite allergens
10/26/1999US5972351 Polypeptides; method of identifying peptides of an antigen of interest which are capable of recognition by or induction of cytotoxic t lymphocytes; vaccines, immunology
10/26/1999US5972350 Prevention and treatment of chlamydia diseases in cats
10/26/1999US5972349 Synthesis of polyribosylribitol phosphate oligosaccharides
10/26/1999US5972348 Nickel binding protein and its encoding dna isolated from helicobacter pylori; useful as vaccine, diagnostic, drug target, and therapy in itself
10/26/1999US5972347 Pharmaceutical composition containing a neutralized virus and use thereof
10/26/1999US5972346 Hepatitis b surface antigen, in combination with aluminum phosphate and 3-o-acylated monophosphoryl lipid a.
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972336 Urease-based vaccine against helicobacter infection
10/26/1999US5972335 Compositions for promoting the healing of wounds or fibrotic disorders comprising at least one agent specific to either a growth factor or a protein associated therewith; antibodies
10/26/1999US5972334 Vaccines for treatment of lymphoma and leukemia
10/26/1999CA2057536C Cloning and expression of borrelia lipoproteins
10/21/1999WO1999053310A1 Antigen
10/21/1999WO1999053099A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999WO1999053061A2 Tumor associated nucleic acids and uses therefor
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053027A1 Use of monocytes derived cells and antibodies in a synergic way for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999053026A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052944A1 G-protein coupled receptors
10/21/1999WO1999052939A1 Peptides
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052928A1 Transporter protein splice variants and model for immune diversity
10/21/1999WO1999052562A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/21/1999WO1999052561A1 Inhibition of xenoreactive antibodies
10/21/1999WO1999052552A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999WO1999052550A1 Polymer particle vaccine delivery system
10/21/1999WO1999052549A1 Adjuvant compositions
10/21/1999WO1999052548A2 Conjugate vaccines for the prevention of dental caries
10/21/1999WO1999052547A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/21/1999WO1999052546A2 A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
10/21/1999WO1999052545A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052507A1 Incorporation of active substances in carrier matrixes
10/21/1999WO1999052503A2 Rna cancer vaccine and methods for its use
10/21/1999WO1999052463A1 Needleless administration of polynucleotide formulations
10/21/1999WO1999046574A3 Antibodies for assessing protein post-translational modification status and methods of making and using the same
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999045119A3 Production of mycobacterial polypeptides by lactic acid bacteria
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999040925A3 Hapten-modified tumor cell membranes and their use
10/21/1999WO1999040113A9 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
10/21/1999WO1999038520A9 Blood cell composition as a vaccine for hiv and other pathogenic organisms
10/21/1999WO1999036105A9 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
10/21/1999WO1999033522A8 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999WO1998041625A8 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999CA2328180A1 Needleless administration of polynucleotide formulations
10/21/1999CA2327339A1 A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
10/21/1999CA2326618A1 Inhibition of xenoreactive antibodies
10/21/1999CA2325939A1 Vaccine
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325576A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2325338A1 Conjugate vaccines for the prevention of dental caries
10/21/1999CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999CA2324981A1 Peptides
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/21/1999CA2323733A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/21/1999CA2321181A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999CA2294018A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999EP0950068A2 Collagen binding protein compositions and methods of use
10/20/1999EP0950065A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
10/20/1999CN1232504A 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of order designated mononegavirales
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999CN1232411A Microencapsulation process using supercritical fluids
10/20/1999CN1232402A Method and compositions for immunomodulation
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/19/1999US5969130 Meningococcal polysaccharide conjugate vaccines
10/19/1999US5969126 GNRH-leukotoxin chimeras
10/19/1999US5969110 Antibodies which are immunoreactive with a human tyrosine kinase ligand protein
10/19/1999US5969109 Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
1 ... 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 ... 1823